Isoray Will Have Prominent Role at American Brachytherapy Society’s Annual Prostate Brachytherapy Workshop
RICHLAND, Wash., Oct. 29, 2019 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR) announced today that it will demonstrate its […]
Gilat and China Satcom Lay Foundation for Future Chinese Satellite Communication for Aero, Maritime, Land Mobility and Fixed Applications
PETAH TIKVA, Israel and BEIJING, Oct. 29, 2019 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide […]
Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
EDMONTON, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology […]
Establishment Labs to Announce Third Quarter 2019 Financial Results on November 12, 2019
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on […]
Chiasma to Report Third Quarter Financial Results on November 5, 2019
WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) — Chiasma, Inc. (Nasdaq: CHMA), a clinical-stage biopharmaceutical company focused on improving the […]
Covetrus Announces Third Quarter 2019 Earnings Release Date and Conference Call Information
PORTLAND, Maine, Oct. 29, 2019 (GLOBE NEWSWIRE) — Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced […]
Chimerix to Announce Third Quarter 2019 Financial Results and Provide an Operational Update on November 5, 2019
DURHAM, N.C., Oct. 29, 2019 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development […]
Franklin Electric Reports Record Third Quarter 2019 Sales and Earnings
FORT WAYNE, Ind., Oct. 29, 2019 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) reported record third quarter 2019 […]
Aileron Therapeutics Announces Positive Nonclinical Myelopreservation Results for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference
Nonclinical research results show that ALRN-6924 prevented the toxic side effects of chemotherapy in normal cells and enhanced the anti-cancer […]
Pluralsight Announces Next Phase of International Expansion with Focus on APAC
Mike Featherstone Appointed Managing Director of ANZ/APACSILICON SLOPES, Utah, Oct. 29, 2019 (GLOBE NEWSWIRE) — Pluralsight, Inc. (NASDAQ: PS), the […]
